NovoCure Limited(NVCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVCR NovoCure Limited

休市中 11-13 16:00:00 EST

11.83

+0.11

+0.94%

盘后11.79

-0.04-0.34%

19:30 EST

最高11.90	最低11.44	成交量105.17万
今开11.70	昨收11.72	日振幅3.97%
总市值13.78亿	流通市值11.52亿	总股本1.16亿
成交额1,230万	换手率1.08%	流通股本9,737万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVCR","market":"US","secType":"STK","nameCN":"NovoCure Limited","latestPrice":11.83,"timestamp":1794603600000,"preClose":11.72,"halted":0,"volume":1051731,"hourTrading":{"tag":"盘后","latestPrice":11.79,"preClose":11.83,"latestTime":"19:30 EST","volume":24810,"amount":293497.18,"timestamp":1794616201949,"change":-0.04,"changeRate":-0.003381,"amplitude":0.003381},"delay":0,"changeRate":0.00938566552901019,"floatShares":97369400,"shares":116445840,"eps":-1.060444,"marketStatus":"休市中","change":0.11,"latestTime":"11-13 16:00:00 EST","open":11.7,"high":11.9,"low":11.435,"amount":12301719.935571,"amplitude":0.039676,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.060444,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1443758400000,"exchange":"NASDAQ","adjPreClose":11.72,"preHourTrading":{"tag":"盘前","latestPrice":11.71,"preClose":11.72,"latestTime":"09:29 EST","volume":680,"amount":7977.84976,"timestamp":1794580199930,"change":-0.01,"changeRate":-0.000853,"amplitude":0.061433},"postHourTrading":{"tag":"盘后","latestPrice":11.79,"preClose":11.83,"latestTime":"19:30 EST","volume":24810,"amount":293497.18,"timestamp":1794616201949,"change":-0.04,"changeRate":-0.003381,"amplitude":0.003381},"volumeRatio":0.6078873090950832,"impliedVol":0.3948,"impliedVolPercentile":0.0279},"requestUrl":"/m/hq/s/NVCR","defaultTab":"news","newsList":[{"id":"1134360251","title":"财报前瞻 | NovoCure Limited本季度营收预计增14.48%，胰腺癌适应症扩张成看点","url":"https://stock-news.laohu8.com/highlight/detail?id=1134360251","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134360251?lang=zh_cn&edition=full","pubTime":"2026-10-22 14:46","pubTimestamp":1792651606,"startTime":"0","endTime":"0","summary":"NovoCure Limited将于2026年10月29日美股盘前发布最新季度财报，市场关注营收与每股收益的同比改善及胰腺癌适应症的商业化进展。公司核心产品线为肿瘤电场治疗相关系统，季度总营收美元1.84亿，同比增长15.60%，受适应症扩展与装机保有量增长推动。结合市场一致预期，本季度营收美元1.82亿、同比增长14.48%，反映胰腺癌适应症进入落地期对总盘的增量贡献。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | NovoCure Limited本季度营收预计增14.48%，胰腺癌适应症扩张成看点","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174805119","title":"Novocure披露数据泄露：超1,400条美国记录的内部患者ID号遭曝光——SEC文件揭示安全漏洞","url":"https://stock-news.laohu8.com/highlight/detail?id=1174805119","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174805119?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:04","pubTimestamp":1788260654,"startTime":"0","endTime":"0","summary":"Novocure公司在一份提交给美国证券交易委员会的文件中透露，一起数据泄露事件波及广泛，涉及超过1,400条美国记录，其中包含内部患者身份识别号码。这一披露引发了外界对医疗行业数据防护措施有效性的深切关注，同时也促使相关方面重新审视内部安全协议的严谨性。随着调查的推进，Novocure表示将采取进一步措施以加强数据安全，并承诺对受影响的个人提供必要的支持与指导。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4082","BK4534","BK4548","NVCR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170942678","title":"NovoCure Limited：坚信此次事件不会对财务状况及经营业绩造成重大影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1170942678","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170942678?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:04","pubTimestamp":1788260651,"startTime":"0","endTime":"0","summary":"NovoCure Limited（简称“NovoCure”）近日明确表示，其不认为所发生的相关事件将对公司财务状况及经营业绩产生实质性影响，亦不构成潜在的重大不利冲击。该公司重申，当前局面仍处于可控范围之内，未动摇其整体运营的基本盘面。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4082","NVCR","BK4548","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123512632","title":"NovoCure二季度营收达1.83584亿美元，超出IBES预期1.724亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1123512632","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123512632?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:13","pubTimestamp":1784805185,"startTime":"0","endTime":"0","summary":"7月23日——NovoCure Limited（NVCR）公布第二季度财务数据，公司营收录得1.83584亿美元，显著超越市场研究机构IBES此前预估的1.724亿美元。然而，同期运营收入出现亏损，为-1056.2万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4534","BK4548","NVCR","BK4082","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196568011","title":"财报前瞻｜NovoCure Limited本季度营收预计增长12.00%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1196568011","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196568011?lang=zh_cn&edition=full","pubTime":"2026-07-16 11:25","pubTimestamp":1784172329,"startTime":"0","endTime":"0","summary":"NovoCure Limited将于2026年07月23日发布最新季度财报，市场关注营收回升与利润修复节奏及核心治疗适应症渗透进展。上季度公司营收1.74亿美元，同比增长12.30%；毛利率77.63%；归属于母公司股东的净利润为亏损7,113.80万美元，净利率-40.87%；调整后每股收益为-0.62美元，同比下降100.00%。多家券商与研究机构强调，上季度净利率-40.87%与调整后每股收益-0.62美元反映短期利润压力，尽管市场预计本季度营收同比增长12.00%、亏损收窄，但可持续性仍待观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜NovoCure Limited本季度营收预计增长12.00%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171392988","title":"NovoCure试验数据：早期启动组中位总生存期17.7个月，维持启动组为17.5个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1171392988","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171392988?lang=zh_cn&edition=full","pubTime":"2026-06-18 19:04","pubTimestamp":1781780665,"startTime":"0","endTime":"0","summary":"NovoCure Limited公布的最新临床试验数据显示，其肿瘤治疗电场疗法在针对特定脑癌患者的试验中取得了积极进展。在关键的总生存期指标上，接受早期干预的患者组（Early Start Arm）中位总生存期达到17.7个月，而对照的维持启动组（Maintenance Start Arm）则为17.5个月。两组数据均显示出该疗法在延长患者生存时间方面的潜力，早期干预组略占优势。\n这一结果对于评估该创新疗法的临床价值具有重要参考意义。尽管两组间差异不大，但数据进一步证实了肿瘤治疗电场疗法作为现有标准治疗方案补充的可行性。公司将继续推进相关临床研究，以获取更全面的疗效与安全性数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4585","NVCR","BK4548","BK4588","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179497465","title":"NovoCure公布三期Trident试验顶线数据，评估肿瘤电场疗法在初诊胶质母细胞瘤中的早期应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1179497465","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179497465?lang=zh_cn&edition=full","pubTime":"2026-06-18 19:01","pubTimestamp":1781780476,"startTime":"0","endTime":"0","summary":"NovoCure Limited公布了其关键三期Trident试验的顶线结果。该研究旨在评估肿瘤电场疗法在初诊胶质母细胞瘤患者中更早介入的疗效与安全性。\n胶质母细胞瘤是一种极具侵袭性的脑癌，治疗选择有限。肿瘤电场疗法是一种利用特定频率电场干扰癌细胞分裂的物理疗法。Trident试验探索了在标准治疗方案（包括手术、放疗和化疗）基础上，于更早阶段联合使用该疗法是否能带来更佳的临床获益。\n此次公布的顶线数据为后续的详细分析和在学术会议及同行评审期刊上的完整结果发布奠定了基础。公司表示，这些数据将用于支持与全球监管机构的沟通，以探讨该疗法在更广泛患者群体中应用的潜在路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4534","BK4082","NVCR","BK4585","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517162511","title":"Novocure Limited2024财年实现净利润-1.69亿美元，同比增加18.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517162511?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:01","pubTimestamp":1741276872,"startTime":"0","endTime":"0","summary":"3月7日，Novocure Limited公布财报，公告显示公司2024财年净利润为-1.69亿美元，同比增加18.36%；其中营业收入为6.05亿美元，同比增加18.86%，每股基本收益为-1.56美元。从资产负债表来看，Novocure Limited总负债8.81亿美元，其中短期债务5.66亿美元，资产负债比为1.41，流动比率为1.47。机构评级：截至2025年3月7日，当前有7家机构对Novocure Limited目标价做出预测，其中目标均价为35.57美元，其中最低目标价为29.00美元，最高目标价为42.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000141a262a624&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000141a262a624&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517237919","title":"Novocure Limited盘中异动 下午盘股价大涨5.06%报19.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517237919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517237919?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:08","pubTimestamp":1741201686,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时08分，Novocure Limited股票出现波动，股价快速拉升5.06%。截至发稿，该股报19.11美元/股，成交量47.8953万股，换手率0.44%，振幅7.61%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为1.27%。其相关个股中，Xylo Technologies Ltd、Trisalus Life Sciences Inc C/Wts 10/08/28 、Intelligent Bio Solutions Inc.涨幅较大，古特拉、908 Devices Inc.、Tivic Health Systems, Inc.较为活跃，换手率分别为68.84%、30.64%、10.63%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Ainos, Inc.、Heartsciences Inc.，振幅分别为40.00%、34.75%、23.28%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030806a2611461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030806a2611461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","NVCR","BK4548","BK4588","BK4082","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516212668","title":"Novocure Limited盘中异动 下午盘大幅跳水5.03%报18.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516212668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516212668?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:20","pubTimestamp":1741033217,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时20分，Novocure Limited股票出现波动，股价快速下挫5.03%。截至发稿，该股报18.11美元/股，成交量65.9658万股，换手率0.60%，振幅4.93%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.80%。其相关个股中，Adagio Medical Holdings, Inc、Senseonics Holdings, Inc.、Ceribell, Inc.涨幅较大，Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Bluejay Diagnostics, Inc.较为活跃，换手率分别为49.97%、18.47%、12.78%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 ，振幅分别为71.96%、59.09%、40.86%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042017abe693de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042017abe693de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCR","BK4548","BK4082","BK4588","BK4534","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320023","title":"Novocure Limited盘中异动 早盘股价大跌5.30%报18.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514320023?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:34","pubTimestamp":1740753254,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时34分，Novocure Limited股票出现异动，股价急速下挫5.30%。截至发稿，该股报18.21美元/股，成交量4.6598万股，换手率0.04%，振幅3.28%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.60%。其相关个股中，Monogram Technologies Inc.、Intelligent Bio Solutions Inc.、Heartsciences Inc.涨幅较大，Rapid Micro Biosystems, Inc.、Dih Holding Us, Inc.、沃氪医疗较为活跃，换手率分别为14.97%、3.98%、2.36%，振幅较大的相关个股有Envveno Medical Corporation、Butterfly Network, Inc.、Ainos, Inc.，振幅分别为16.15%、10.19%、8.94%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223414abe0eb6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223414abe0eb6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4585","BK4588","BK4548","BK4082","NVCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166495530","title":"异动解读 | NovoCure 2024年Q4净亏损超预期 股价盘中大跌8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166495530","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166495530?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:45","pubTimestamp":1740667507,"startTime":"0","endTime":"0","summary":"NovoCure Limited(纳斯达克代码:NVCR)今日盘中大跌8.38%,引发了市场广泛关注。\n\n公司2024年第四季度财报显示,尽管该季度营收1.61亿美元高于市场预期的1.58亿美元,但每股净亏损为0.61美元,却大幅超出分析师共识预期的0.34美元亏损水平。\n\n净亏损数据遭超预期,显然令投资者失望,这可能是导致NovoCure股价盘中大幅震荡下跌的主要原因。市场对公司盈利能力存疑,在此前景不佳的财报出炉后,投资者或选择先行减持股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514628385","title":"Novocure Limited盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514628385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514628385?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666737,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Novocure Limited股票出现波动，股价急速下挫5.10%。截至发稿，该股报20.84美元/股，成交量3.9549万股，换手率0.04%，振幅4.87%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.03%。其相关个股中，Dih Holdings Us Inc C/Wts 20/04/2028 、Biomerica, Inc.、Establishment Labs Holdings Inc.涨幅较大，Bone Biologics Corp、Reshape Lifesciences, Inc.、Tandem Diabetes Care, Inc.较为活跃，换手率分别为3.37%、2.68%、1.11%，振幅较大的相关个股有Beyond Air, Inc.、Tandem Diabetes Care, Inc.、Standard Biotools Inc.，振幅分别为16.76%、9.59%、8.55%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223217abdf6ec8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223217abdf6ec8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4534","BK4585","BK4548","BK4588","NVCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198797301","title":"NovoCure 2024年第四季度GAAP每股收益$(0.61)不及预期$(0.34)，销售额$1.6127亿高于预期$1.5781亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1198797301","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198797301?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:10","pubTimestamp":1740658225,"startTime":"0","endTime":"0","summary":"NovoCure  报告称季度每股亏损$，未达到分析师共识预期的$，差79.41%。这比去年同期每股亏损$下降了35.56%。公司报告季度销售额为1.6127亿美元，高于分析师共识预期的1.5781亿美元，增长2.19%。以上内容来自Benzinga Earnings专栏，原文如下：NovoCure  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 79.41 percent. This is a 35.56 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $161.27 million which beat the analyst consensus estimate of $157.81 million by 2.19 percent.  This is a 20","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NovoCure 2024年第四季度GAAP每股收益$(0.61)不及预期$(0.34)，销售额$1.6127亿高于预期$1.5781亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514859851","title":"Novocure Limited盘中异动 早盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514859851?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:04","pubTimestamp":1740582267,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时04分，Novocure Limited股票出现异动，股价快速拉升5.00%。截至发稿，该股报22.05美元/股，成交量12.8599万股，换手率0.12%，振幅4.59%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.55%。其相关个股中，Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、沃氪医疗、麦斯莫医疗涨幅较大，Venus Concept Inc.、Sintx Technologies, Inc.、Biomerica, Inc.较为活跃，换手率分别为12.47%、11.59%、10.38%，振幅较大的相关个股有Inogen, Inc、Rapid Micro Biosystems, Inc.、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 ，振幅分别为33.09%、18.09%、17.14%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230427963155fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230427963155fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","NVCR","BK4082","BK4548","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511661596","title":"Novocure Limited盘中异动 快速拉升5.67%报22.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511661596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511661596?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:50","pubTimestamp":1739555451,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时50分，Novocure Limited股票出现异动，股价急速拉升5.67%。截至发稿，该股报22.94美元/股，成交量32.9524万股，换手率0.30%，振幅4.84%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.38%。其相关个股中，Avita Medical, Inc.、Pacific Biosciences Of California, Inc.、Envoy Medical Inc C/Wts 29/09/2028 涨幅较大，Nanovibronix, Inc.、Tivic Health Systems, Inc.、Nano-X Imaging Ltd较为活跃，换手率分别为221.08%、66.42%、12.93%，振幅较大的相关个股有Dih Holdings Us Inc C/Wts 20/04/2028 、Nanovibronix, Inc.、Nexalin Technology Inc C/Wts ，振幅分别为75.00%、62.27%、44.63%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015051a2462bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015051a2462bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4548","BK4534","BK4082","NVCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509878392","title":"Novocure Limited盘中异动 大幅下挫5.05%报22.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509878392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509878392?lang=zh_cn&edition=full","pubTime":"2025-02-07 03:33","pubTimestamp":1738870433,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日03时33分，Novocure Limited股票出现异动，股价大幅下挫5.05%。截至发稿，该股报22.96美元/股，成交量49.7615万股，换手率0.46%，振幅5.00%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.71%。其相关个股中，Trisalus Life Sciences Inc C/Wts 10/08/28 、Nevro Corp.、Nanovibronix, Inc.涨幅较大，Nevro Corp.、Nanovibronix, Inc.、Sensus Healthcare, Inc.较为活跃，换手率分别为27.39%、22.96%、14.83%，振幅较大的相关个股有Nanovibronix, Inc.、Tenon Medical Inc C/Wts 16/06/2028 、Hyperfine, Inc.，振幅分别为32.16%、30.81%、30.25%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033355961a4476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033355961a4476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCR","BK4548","BK4534","BK4585","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503640967","title":"Novocure Limited盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503640967?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951535,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Novocure Limited股票出现异动，股价快速上涨5.26%。截至发稿，该股报27.61美元/股，成交量2.3549万股，换手率0.02%，振幅1.95%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.37%。其相关个股中，908 Devices Inc.、Helius Medical Technologies, Inc.、Quantum-Si Incorporated涨幅较大，Helius Medical Technologies, Inc.、Catheter Precision, Inc.、Quantum-Si Incorporated较为活跃，换手率分别为522.83%、44.88%、4.43%，振幅较大的相关个股有Lifeward Ltd.、908 Devices Inc.、Ainos, Inc.，振幅分别为10.27%、9.09%、8.57%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223216a222fe13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223216a222fe13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4534","BK4082","NVCR","BK4585","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502893651","title":"Novocure Limited盘中异动 股价大跌5.12%报27.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502893651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502893651?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:48","pubTimestamp":1736520496,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时48分，Novocure Limited股票出现波动，股价快速下挫5.12%。截至发稿，该股报27.43美元/股，成交量7.1414万股，换手率0.07%，振幅3.15%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.06%。其相关个股中，Ainos, Inc.、Baird Medical Investment Hldgs Ltd C/Wts 01/10/2029 、Senseonics Holdings, Inc.涨幅较大，Inspira Technologies Oxy B.H.N. Ltd.、Ainos, Inc.、Transmedics Group, Inc.较为活跃，换手率分别为109.29%、29.36%、5.57%，振幅较大的相关个股有Ainos, Inc.、Dih Holdings Us Inc C/Wts 20/04/2028 、Biosig Technologies, Inc.，振幅分别为55.23%、17.80%、16.79%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110224816aba60710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110224816aba60710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4585","NVCR","BK4548","BK4588","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492310870","title":"Novocure Limited盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492310870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492310870?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:30","pubTimestamp":1734622235,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日23时30分，Novocure Limited股票出现波动，股价急速下跌5.04%。截至发稿，该股报29.95美元/股，成交量20.2804万股，换手率0.19%，振幅6.37%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.20%。其相关个股中，Baird Medical Investment Hldgs Ltd C/Wts 01/10/2029 、Baird Medical Investment Holdings Ltd、Adagio Medical Holdings, Inc涨幅较大，Aethlon Medical, Inc.、Nuwellis, Inc.、Quantum-Si Incorporated较为活跃，换手率分别为37.06%、22.37%、4.97%，振幅较大的相关个股有Baird Medical Investment Holdings Ltd、Dih Holdings Us Inc C/Wts 20/04/2028 、Nanovibronix, Inc.，振幅分别为48.39%、40.75%、23.58%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219233035ab84b8cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219233035ab84b8cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","NVCR","BK4534","BK4585","BK4588","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novocure.com","stockEarnings":[{"period":"1week","weight":-0.1092},{"period":"1month","weight":-0.1452},{"period":"3month","weight":-0.3021},{"period":"6month","weight":-0.3271},{"period":"1year","weight":0.0395},{"period":"ytd","weight":-0.0851}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novocure Limited是一家于2000年2月11日根据海峡群岛泽西岛法律注册成立的公共有限责任公司。它是一家全球肿瘤学公司，开发了一种被称为肿瘤治疗领域（TTFields）的专有平台技术，该技术利用电场杀死癌细胞。NovoCure的关键商业产品包括Optune Gio、Optune Lua和Optune Pax，它们通过医疗设备提供TTFields疗法。该公司的主要重点是推动其产品的商业采用，获得新适应症的监管批准，以及推进旨在提高侵袭性癌症总生存期的临床项目。NovoCure在多个国家销售其产品，其收入的很大一部分来自美国、德国、法国和日本的市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.026321},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.001726},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.034505},{"month":4,"riseRate":0.545455,"avgChangeRate":0.108267},{"month":5,"riseRate":0.818182,"avgChangeRate":0.133305},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.03448},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.006046},{"month":8,"riseRate":0.636364,"avgChangeRate":0.035375},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.028188},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.099312},{"month":11,"riseRate":0.583333,"avgChangeRate":0.062499},{"month":12,"riseRate":0.545455,"avgChangeRate":0.065178}],"exchange":"NASDAQ","name":"NovoCure Limited","nameEN":"NovoCure"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NovoCure Limited(NVCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NovoCure Limited(NVCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NovoCure Limited,NVCR,NovoCure Limited股票,NovoCure Limited股票老虎,NovoCure Limited股票老虎国际,NovoCure Limited行情,NovoCure Limited股票行情,NovoCure Limited股价,NovoCure Limited股市,NovoCure Limited股票价格,NovoCure Limited股票交易,NovoCure Limited股票购买,NovoCure Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NovoCure Limited(NVCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NovoCure Limited(NVCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}